🇺🇸 FDA
Patent

US 9708310

Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof

granted A61PA61P35/00

Quick answer

US patent 9708310 (Phenanthroindolizidine and phenanthroquinolizidine alkaloid having a hydroxyl group on the phenanthrene ring thereof, preparation method and use thereof) held by China Medical University expires Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
China Medical University
Grant date
Tue Jul 18 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 13 2037 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
10
CPC classes
A61P, A61P35/00